SMTL ID : 5gwy.1

Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.85 Å

Oligo State

homo-dimer

Ligands

2 x 02J- ALA- VAL- LEU- PJE- 010: N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE(Non-covalent)

02J-ALA-VAL-LEU-PJE-010.1: 21 residues within 4Å: Chain B: T.30, V.31, H.46, T.52, I.56, F.144, I.145, G.147, C.149, H.168, Q.169, I.170, E.171, L.172, G.173, H.177, D.192, Q.193, P.194, S.195, L.196 14 PLIP interactions: 14 interactions with chain B Hydrophobic interactions: B:T.30, B:I.56, B:I.170, B:L.172, B:L.196 Hydrogen bonds: B:G.147, B:Q.169, B:E.171, B:E.171, B:E.171, B:G.173, B:S.195 Water bridges: B:Q.197, B:Q.197 02J-ALA-VAL-LEU-PJE-010.2: 21 residues within 4Å: Chain A: T.30, V.31, L.32, H.46, I.56, F.144, I.145, G.147, C.149, H.168, Q.169, I.170, E.171, G.173, H.177, D.192, Q.193, P.194, S.195, L.196 Chain B: L.3 14 PLIP interactions: 13 interactions with chain A, 1 interactions with chain B Hydrophobic interactions: A:T.30, A:I.56, A:I.170, A:D.192, A:L.196, B:L.3 Hydrogen bonds: A:G.147, A:Q.169, A:E.171, A:E.171, A:E.171, A:S.195 Water bridges: A:Q.197 Salt bridges: A:H.46

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, F. et al., Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design. Sci Rep (2016)

Release Date

2017-09-20

Peptides

main protease: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

main protease